Acclinate Logo
Talk to Our Team

In the dynamic realm of clinical research our commitment to Diversity, Equity, and Inclusion (DE&I) stands as a cornerstone for positive change. Acclinate, in partnership with Advarra, is excited to present our Trend Report: DE&I in Clinical Research – a comprehensive exploration of where our inclusivity efforts stand today with tangible recommendations for improving representation in the year ahead. 

‍Clinical trials, crucial for medical progress, often grapple with a lack of diverse representation. Recent FDA directives have emphasized the industry's imperative to embrace inclusivity, steering the research landscape toward a more equitable future.‍

Our joint report unveils key findings, from awareness and confidence levels to strategies for diverse enrollment, providing insights into the elements shaping the path towards inclusivity.

Exploring financial dynamics, we delve into the budgetary impact on recruitment and relationship building. As our path to diversity and health equity continues , we present a blueprint for progress, emphasizing the collective responsibility of stakeholders in fostering inclusivity.

Clinical research isn't just about trials; it's about shaping the future of healthcare. Our Trend Report serves as a call to action, urging the industry to address disparities actively and embrace historically excluded populations.

From actionable insights to tangible ideas, join us in charting the course toward positive change.

Download the full report

 

Recent Posts

Health Tech for Inclusive Research Starts with Representation
5 Min Read

Key Takeaways and Learnings Health tech for inclusive research must be built with representation at the forefront—from design to deployment. Exclusion...

Read More
Keep Personalization Alive: Building Scalable Tech That Serves Every Community
4 Min Read

When I think about the role of technology in healthcare, I feel both excited and cautious. Excited, because scaling technology means we can reach more...

Read More
Improve Diversity in Clinical Trials Without Slowing Progress
4 Min Read

Key Takeaways and Learnings The belief that representation slows clinical trials is outdated—early inclusion strategies often speed them up. Retention...

Read More
Why Diverse Clinical Trials Yield Smarter, Safer Science
4 Min Read

Key Takeaways and Learnings Diverse clinical trials yield smarter, safer science by making results more generalizable and interventions more effective...

Read More
Turning Data Into Direction: Business Intelligence as a Catalyst for Inclusive Research
3 Min Read

I learned to respect business intelligence (BI) in hospitals and health systems, where every decision felt urgent and the stakes were always high. In ...

Read More
6 Proven Strategies for Representative Trial Recruitment
5 Min Read

Key Takeaways and Learnings One-size-fits-all efforts don’t result in inclusive participant outreach plans that work. Predictive analytics, community ...

Read More
Reduce Recruitment Risk in Pharma Through Representation
4 Min Read

Key Takeaways and Learnings Underrepresentation slows recruitment, increases dropout risk, and weakens data reliability. Proactive inclusion strategie...

Read More
Beyond Compliance: Building Trust Through Robust Data Security and Ethical Practices
3 Min Read

In clinical research, data is everything. It’s the foundation of scientific discovery, the evidence behind regulatory approvals, and the key to develo...

Read More
How to Reach Diverse Patients for Clinical Trials—and Engage Them
5 Min Read

Key Takeaways and Learnings Traditional “one-size-fits-all” recruitment fails to address the barriers and concerns of underrepresented communities. Or...

Read More